Prevalence of the antiheparin-platelet factor 4 antibody in hemodialysis (HD) patients and its effects upon dialysis access.
Wallace
K
K
Dasgupta
I
I
Stratton
J
J
Johnston
P
P
Parry
R
R
D000906:Antibodies / Q000097:blood*; D004739:England; D004797:Enzyme-Linked Immunosorbent Assay; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology*; D006801:Humans; D015994:Incidence; D010978:Platelet Factor 4 / Q000276:immunology*; D010979:Platelet Function Tests; D015995:Prevalence; D006435:Renal Dialysis / Q000009:adverse effects; D013921:Thrombocytopenia / Q000097:blood / Q000453:epidemiology / Q000209:etiology*; D013927:Thrombosis / Q000097:blood / Q000453:epidemiology / Q000209:etiology*
D000906:Antibodies; D010978:Platelet Factor 4; D006493:Heparin